The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells.

Saved in:
Bibliographic Details
Title: The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells.
Authors: Di Muro G; Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.; Department of Experimental Medicine, University Sapienza of Rome, 00100 Rome, Italy., Catalano R; Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy., Treppiedi D; Endocrinology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy., Barbieri AM; Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy., Mangili F; Endocrinology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy., Marra G; Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy., Di Bari S; Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy., Esposito E; Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.; PhD Program in Experimental Medicine, University of Milan, 20100 Milan, Italy., Nozza E; Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.; PhD Program in Experimental Medicine, University of Milan, 20100 Milan, Italy., Lania AG; Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Italy.; Endocrinology and Diabetology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, 20089 Rozzano, Italy., Ferrante E; Endocrinology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy., Locatelli M; Neurosurgery Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy., Modena D; Preclinical R&D, Italfarmaco Group, Cinisello Balsamo, 20092 Milan, Italy., Steinkuhler C; Preclinical R&D, Italfarmaco Group, Cinisello Balsamo, 20092 Milan, Italy., Peverelli E; Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.; Endocrinology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy., Mantovani G; Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.; Endocrinology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Source: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 23; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 23.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1422-0067
DOI:10.3390/ijms25073606